Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe Rheumatoid Arthritis”

263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 263 results

Testing effectiveness (Phase 2)Study completedNCT00595413
What this trial is testing

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Who this might be right for
Rheumatoid Arthritis
EMD Serono 311
Large-scale testing (Phase 3)Study completedNCT04512001
What this trial is testing

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 604
Post-approval studies (Phase 4)Study completedNCT01331837
What this trial is testing

Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 3,080
Large-scale testing (Phase 3)Study completedNCT01655381
What this trial is testing

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 15
Very early researchLooking for participantsNCT07526350
What this trial is testing

MTS109 in Patients With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis (SSc)+2 more
Shanghai Changzheng Hospital 15
Not applicableStudy completedNCT05170646
What this trial is testing

An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 97
Post-approval studies (Phase 4)Study completedNCT02187055
What this trial is testing

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Who this might be right for
Rhematoid Arthritis
Pfizer 1,152
Post-approval studies (Phase 4)Study completedNCT05660655
What this trial is testing

Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 94
Large-scale testing (Phase 3)Study completedNCT03789292
What this trial is testing

Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 648
Testing effectiveness (Phase 2)Study completedNCT01565655
What this trial is testing

Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Astellas Pharma Global Development, Inc. 289
Testing effectiveness (Phase 2)Looking for participantsNCT06972446
What this trial is testing

Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 180
Not applicableStudy completedNCT03387423
What this trial is testing

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,459
Large-scale testing (Phase 3)Study completedNCT00891020
What this trial is testing

Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 886
Post-approval studies (Phase 4)Ended earlyNCT01251120
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 2
Not applicableStudy completedNCT01672970
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Not applicableStudy completedNCT01667458
What this trial is testing

An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Study completedNCT02296775
What this trial is testing

Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Dr. Reddy's Laboratories Limited 276
Not applicableUnknownNCT03798028
What this trial is testing

The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Xijing Hospital 250
Testing effectiveness (Phase 2)Study completedNCT01649999
What this trial is testing

Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects

Who this might be right for
Arthritis, Rheumatoid
Astellas Pharma Inc 281
Post-approval studies (Phase 4)Study completedNCT00848354
What this trial is testing

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Who this might be right for
Rheumatoid Arthritis
Pfizer 429
Next Page